| Literature DB >> 30850753 |
Yi-Han Jhuang1, Tung-Wei Kao1,2, Tao-Chun Peng1,2, Wei-Liang Chen1,2,3, Yen-Wei Li1, Pi-Kai Chang3,4, Li-Wei Wu5,6,7.
Abstract
The neutrophil-to-lymphocyte ratio (NLR) has received much attention in recent decades and has been a novel inflammatory marker. NLR has been applied in predicting the prognosis of malignancies, mortality, and chronic diseases. Additionally, hypertension, defined as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90 mm Hg, a previous diagnosis of hypertension, and taking any antihypertensive drug, has been one of the most common chronic diseases in Asia and is currently the most important risk factor for cardiovascular diseases worldwide. Thus, we aimed to investigate the correlation between NLR and prevalent hypertension in the Taiwanese population. From the data of routine health checkups at the General Health Promotion Center in the Tri-Service General Hospital (TSGH), a total of 6278 participants were included. The NLR value was divided into tertiles. The Cox regression model revealed that the highest NLR group tended to be hypertensive (HR = 1.28, 95% CI 1.03-1.59) after adjustment. Individuals were also divided into age-specific, BMI-specific, or sex-specific groups; compared with the lowest NLR group, elderly individuals in the highest tertile of NLR were relatively likely to be hypertensive after covariate adjustment (HR = 1.88, 95% CI 1.19-2.96). Furthermore, a male group aged more than 60 years was reported to have a significant association with hypertension (HR = 1.84, 95% CI 1.06-3.18). However, there was no significant difference in the BMI-based stratified groups, even after adjustment. Our research revealed a significant association between the NLR and incident hypertension, especially in elderly or male Taiwanese individuals.Entities:
Keywords: Hypertension; Neutrophil-to-lymphocyte ratio (NLR); Taiwan
Mesh:
Year: 2019 PMID: 30850753 PMCID: PMC8075864 DOI: 10.1038/s41440-019-0245-3
Source DB: PubMed Journal: Hypertens Res ISSN: 0916-9636 Impact factor: 3.872
Baseline characteristics of study group were categorized based on the tertile of neutrophil lymphocyte ratio and represented as means (SD) and proportion (number)
| Tertile of neutrophil lymphocyte ratio | ||||
|---|---|---|---|---|
| T1 (<1.46) | T2: (1.46–2.02) | T3 (≥2.02) | ||
| Continuous variables | ||||
| Sample size ( | 2106 | 2065 | 2107 | |
| Mean age | 40.6 (12.8) | 41.0 (12.6) | 42.0 (12.9) | <0.01 |
| BMI (kg/m2) | 23.4 (3.6) | 23.6 (3.7) | 23.6 (3.9) | 0.03 |
| Systolic BP (mm Hg) | 113.2 (17.1) | 113.1 (18.3) | 114.1 (26.8) | 0.29 |
| Diastolic BP (mm Hg) | 72.0 (11.3) | 72.3 (12.1) | 72.3 (11.3) | 0.70 |
| Serum WBC (103/μL) | 5.75 (1.42) | 6.12 (1.41) | 6.94 (1.86) | <0.01 |
| Serum HDL-cholesterol (mg/dL) | 59.1 (16.4) | 57.1 (16.0) | 57.0 (15.9) | <0.01 |
| Serum triglycerides (mg/dL) | 106.2 (107.5) | 111.7 (106.4) | 106.9 (73.5) | 0.17 |
| Serum cholesterol (mg/dL) | 187.5 (35.4) | 187.3 (35.7) | 184.0 (34.7) | <0.01 |
| Serum BUN (mg/dL) | 13.1 (3.5) | 13.0 (3.5) | 12.8 (4.4) | 0.20 |
| Serum creatinine (mg/dL) | 0.8 (0.3) | 0.8 (0.3) | 0.8 (0.4) | 0.10 |
| Serum uric acid (mg/dL) | 5.5 (1.5) | 5.6 (2.3) | 5.5 (1.5) | 0.06 |
| Categorical variables | ||||
| Male, % ( | 52.5 (1106) | 51.0 (1053) | 46.0 (969) | <0.01 |
| History of smoking ( | 218 | 260 | 286 | 0.01 |
SD standard deviation, BMI body mass index, BP blood pressure, WBC white blood cell, HDL high-density lipoprotein, BUN blood urea nitrogen
HRs of tertiles of neutrophil lymphocyte ratio for hypertension based on the age, gender, and BMI groups
| Characteristics | Neutrophil lymphocyte ratios (tertiles) | ||||
|---|---|---|---|---|---|
| T1 (<1.46) | T2 (1.46–2.02) | T3 (≥2.02) | |||
| HR (95% CI) | HR (95% CI) | HR (95% CI) | |||
|
| 1 (reference) | 1.05 (0.84–1.30) | 0.67 | 1.22 (0.99–1.51) | 0.07 |
| Age (years) | |||||
| <40 | 1 (reference) | 1.18 (0.71–1.95) | 0.53 | 0.88 (0.52–1.50) | 0.65 |
| 40–60 | 1 (reference) | 0.94 (0.70–1.26) | 0.68 | 1.21 (0.91–1.61) | 0.20 |
| ≥60 | 1 (reference) | 1.38 (0.89–2.16) | 0.15 | 2.05 (1.34–3.13) | <0.01 |
| Gender | |||||
| Male | 1 (reference) | 1.04 (0.79–1.35) | 0.80 | 1.34 (1.03–1.75) | 0.03 |
| Female | 1 (reference) | 1.09 (0.75–1.59) | 0.66 | 1.21 (0.84–1.74) | 0.30 |
| Body mass index | |||||
| <18.5 | 1 (reference) | 3.65 (0.40–33.38) | 0.25 | 1.39 (0.09–22.86) | 0.82 |
| 18.5–24 | 1 (reference) | 1.00 (0.68–1.47) | 0.99 | 1.23 (0.85–1.79) | 0.27 |
| 24–27 | 1 (reference) | 1.09 (0.74–1.60) | 0.67 | 1.23 (0.84–1.80) | 0.28 |
| ≥27 | 1 (reference) | 0.99 (0.67–1.46) | 0.96 | 1.04 (0.72–1.52) | 0.83 |
|
| 1 (reference) | 1.13 (0.85–1.39) | 0.35 | 1.28 (1.03–1.59) | 0.03 |
| Age (years) | |||||
| <40 | 1 (reference) | 0.81 (0.48–1.37) | 0.44 | 0.56 (0.31–0.99) | 0.05 |
| 40–60 | 1 (reference) | 1.01 (0.75–1.36) | 0.96 | 1.31 (0.97–1.79) | 0.08 |
| ≥60 | 1 (reference) | 1.31 (0.83–2.07) | 0.25 | 1.88 (1.19–2.96) | 0.01 |
| Gender | |||||
| Male | 1 (reference) | 1.02 (0.78–1.35) | 0.86 | 1.24 (0.94–1.65) | 0.13 |
| Female | 1 (reference) | 1.24 (0.84–1.82) | 0.27 | 1.17 (0.79–1.73) | 0.43 |
| Body mass index | |||||
| <18.5 | 1 (reference) | 18.73 (0.47–744) | 0.12 | 5.73 (0.04–905) | 0.50 |
| 18.5–24 | 1 (reference) | 0.88 (0.60–1.30) | 0.53 | 1.11 (0.74–1.66) | 0.63 |
| 24–27 | 1 (reference) | 1.12 (0.75–1.69) | 0.57 | 1.25 (0.83–1.88) | 0.29 |
| ≥27 | 1 (reference) | 1.18 (0.79–1.76) | 0.42 | 1.21 (0.80–1.83) | 0.38 |
Adjusted models were crude models adjusted for age, sex, BMI, serum WBC, serum total cholesterol, serum HDL-C, and smoking history
HR hazard ratio, CI confidence interval, BMI body mass index, WBC white blood cell, HDL-C high-density lipoprotein cholesterol
HRs of tertiles of neutrophil lymphocyte ratio for hypertension based on the age- and gender-specific groups
| Characteristics | Neutrophil lymphocyte ratios (tertiles) | ||||
|---|---|---|---|---|---|
| T1 (<1.46) | T2 (1.46–2.02) | T3 (≥2.02) | |||
| HR (95% CI) | HR (95% CI) | HR (95% CI) | |||
|
| |||||
| Male | |||||
| Age < 60 | 1 (reference) | 0.94 (0.69–1.28) | 0.69 | 1.13 (0.83–1.56) | 0.44 |
| Age ≥ 60 | 1 (reference) | 1.47 (0.87–2.49) | 0.15 | 2.09 (1.26–3.49) | 0.01 |
| Female | |||||
| Age < 60 | 1 (reference) | 1.27 (0.83–1.95) | 0.28 | 1.35 (0.89–2.05) | 0.16 |
| Age ≥ 60 | 1 (reference) | 1.03 (0.42–2.53) | 0.94 | 1.89 (0.83–4.30) | 0.13 |
|
| |||||
| Male | |||||
| Age < 60 | 1 (reference) | 0.92 (0.67–1.27) | 0.62 | 1.08 (0.77–1.51) | 0.65 |
| Age ≥ 60 | 1 (reference) | 1.34 (0.77–2.32) | 0.30 | 1.84 (1.06–3.18) | 0.03 |
| Female | |||||
| Age < 60 | 1 (reference) | 1.30 (0.84–2.01) | 0.24 | 1.14 (0.73–1.78) | 0.57 |
| Age ≥ 60 | 1 (reference) | 1.05 (0.42–2.67) | 0.91 | 2.08 (0.87–4.97) | 0.10 |
Adjusted models were crude models adjusted for age, sex, BMI, serum WBC, serum total cholesterol, serum HDL-C, and smoking history
HR hazard ratio, CI confidence interval, BMI body mass index, WBC white blood cell, HDL-C high-density lipoprotein cholesterol